Congenital adrenal hyperplasia (patient information): Difference between revisions
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
==Copyleft Sources== | ==Copyleft Sources== | ||
http://www.mayoclinic.com/print/congenital-adrenal-hyperplasia/DS00915/METHOD=print&DSECTION=all | http://www.mayoclinic.com/print/congenital-adrenal-hyperplasia/DS00915/METHOD=print&DSECTION=all | ||
http://www.nlm.nih.gov/medlineplus/ency/article/000411.htm | http://www.nlm.nih.gov/medlineplus/ency/article/000411.htm | ||
Line 25: | Line 24: | ||
[[Category:Intersexuality]] | [[Category:Intersexuality]] | ||
[[Category:Genetics]] | [[Category:Genetics]] | ||
[[Category:Patient | [[Category:Patient information]] | ||
[[Category:Genetic disorders patient information]] | [[Category:Genetic disorders patient information]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 19:14, 1 August 2011
For the WikiDoc page for this topic, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Jinhui Wu, M.D.
Overview
Congenital adrenal hyperplasia refers to genetic disorders of the adrenal glands. It includes a group of autosomal recessive conditions resulting from biochemical paths of the steroidogenesis of cortisol from cholesterol by the adrenal glands. These diseases are 21-hydroxylase deficiency, 17α-hydroxylase deficiency, 11β-hydroxylase deficiency, 3β-hydroxysteroid dehydrogenase deficiency, etc. Among them, almost 95% of cases of congenital adrenal hyperplasia are due to 21-hydroxylase deficiency. Gene mutations are the cause of these diseases. Most of these disorders can interfere with normal growth and development in children and adults.
See also
Copyleft Sources
http://www.mayoclinic.com/print/congenital-adrenal-hyperplasia/DS00915/METHOD=print&DSECTION=all http://www.nlm.nih.gov/medlineplus/ency/article/000411.htm http://www.nichd.nih.gov/health/topics/Congenital_Adrenal_Hyperplasia.cfm